AIVITA gets IND nod for Phase 1B melanoma trial
Clinical Research | News | 0 Comment | 17 Jan, 2019
AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced that the U.S. Fo...Read more
United Neuroscience gets positive results from Ph2a trial for Alzheimer's vaccine
Clinical Research | News | 0 Comment | 17 Jan, 2019
United Neuroscience (UNS), a clinical-stage biotech company pioneering a new class of medicine to treat and prevent brai...Read more
Bridge Bio receives FDA ODD for IPF drug
Clinical Research | News | 0 Comment | 17 Jan, 2019
Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea and a tenant compan...Read more
Immunocore names David Berman as Head of R&D
Clinical Research | News | 0 Comment | 16 Jan, 2019
Clinical-Stage Biotechnology company, Immunocore has announced David Berman as its new Head of Research and Development....Read more
Innovent announces dosing of patient in a Ph1 clinical trial of Anti-CD47 MAb
Clinical Research | News | 0 Comment | 16 Jan, 2019
Innovent Biologics, a world-class biopharmaceutical company that develops and commercializes high quality medicines has ...Read more
NIH starts clinical trial for FMT
Clinical Research | News | 0 Comment | 15 Jan, 2019
A research consortium of NIH recently began enrolling patients in a clinical trial examining whether fecal microbiota tr...Read more
UroGen Pharma announces positive results of UGN-101
Clinical Research | News | 0 Comment | 14 Jan, 2019
A clinical stage pharma company, UroGen Pharma developing treatments to address unmet needs in the field of urology has ...Read more
CellMax, Medigen partner for cell therapy clinical trials
Clinical Research | News | 0 Comment | 11 Jan, 2019
CellMax Life, a US based diagnostics company with a proprietary technology to detect precancer and cancer cells in blood...Read more
Forbius announces the first patient dosed in a Phase 1 trial of AVID200
Clinical Research | News | 0 Comment | 09 Jan, 2019
Forbius, a clinical-stage company developing biologics for the treatment of cancer and fibrosis, announced that the firs...Read more
Immutep collaborates with CYTLIMIC
Clinical Research | News | 0 Comment | 08 Jan, 2019
Immutep Limited has announced that it has entered into a clinical trial collaboration agreement, a supply agreement and ...Read more
Solasia initiates Phase III programme for PledOx
Clinical Research | News | 0 Comment | 07 Jan, 2019
Solasia Pharma K.K. has announced the initiation of Phase III clinical trial for PledOx in Japan. In November 2017, Sol...Read more
USFDA approves Portola Pharmaceuticals’ Andexxa®
Clinical Research | News | 0 Comment | 03 Jan, 2019
Portola Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s ...Read more
Apellis Pharmaceuticals provides update on its Phase 3 program
Clinical Research | News | 0 Comment | 01 Jan, 2019
Apellis Pharmaceuticals Inc. has provided an update on the status of its Phase 3 program for APL-2 in patients with...Read more
Apellis Pharmaceuticals’ APL-2 receives orphan drug designation from the FDA
Clinical Research | News | 0 Comment | 01 Jan, 2019
Apellis Pharmaceuticals Inc., a clinical-stage biopharmaceutical company focused on the development of novel therap...Read more
Bridge Bio announces activation of clinical trial sites for Phase 2 study of UC drug candidate
Clinical Research | News | 0 Comment | 28 Dec, 2018
Bridge Biotherapeutics Inc, a clinical stage biotech company headquartered in Seongnam, South Korea has announced that t...Read more
Vedanta Biosciences Initiates Phase 2 Study for VE303
Clinical Research | News | 0 Comment | 27 Dec, 2018
Clinical Stage company, Vedanta Biosciences developing a new category of therapies for immune-mediated diseases based on...Read more
Merck, Pfizer to terminate Phase III JAVELIN Ovarian 100 trial of avelumab
Clinical Research | News | 0 Comment | 26 Dec, 2018
Merck and Pfizer Inc. has announced that data from a planned interim analysis of the Phase III JAVELIN Ovarian 100 study...Read more
Patrys’s drug suppresses breast cancer brain metastases, increases survival
Clinical Research | News | 0 Comment | 24 Dec, 2018
Singapore - Patrys Limited, a therapeutic antibody development company, is pleased to announce further pre-clinica...Read more